PRIME Education at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
PRIME Education takes part in 2 sessions at ASH 2026 in New Orleans. Its presence centres on applying new evidence in lymphoma care, with bispecific antibodies for diffuse large B-cell and follicular lymphoma and CAR T across non-Hodgkin lymphoma.
| Organization | ASH 2026 Attendance |
|---|---|
Accredited continuing medical education company producing programs for oncology and hematology care teams. | Symposium Fri Dec 11 11:00am–2:00pm Bispecific Antibodies in Action: Applying Evidence Across the DLBCL and FL Care Continuum Bispecific antibodies in relapsed diffuse large B-cell and follicular lymphoma, from sequencing with CAR-T to outpatient step-up dosing and side effects. Symposium Fri Dec 11 3:00pm–6:00pm Evidence at Every Step: Applying the Latest CAR T-Cell Data Across the NHL Care Continuum Getting relapsed lymphoma patients to CAR-T sooner, with earlier referral, bridging therapy, sequencing choices, and management of immune and nerve toxicities. |
Instantly find 20 buyers from PRIME Education
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction